Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

A new syndrome was linked to two new genetic changes in the MBTPS1 gene in a 14-year-old girl.

Certain genes may influence hair loss differently in men and women.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Researchers developed a quick and accurate method to measure hormones in urine, confirming a baldness treatment's effectiveness without altering hormone levels.

A reliable method was developed to measure Finasteride and Tadalafil in rat blood.

64 drugs can cause hair loss, needing better monitoring and updated labels.

Certain gene variants can influence acne risk and severity.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Certain VDR gene changes can affect melanoma risk.

The HGCA tool helps identify genes that work together by analyzing their co-expression patterns.

Certain gene variations and different levels of BDNF and CRH hormones are linked to vitiligo.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

The Potts-Guy model best predicts skin permeability for the tested drugs.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Alopecia areata may be linked to scalp microbiome differences, suggesting potential treatments with prebiotics, probiotics, and postbiotics.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Certain blood metabolites are linked to female pattern hair loss, with some increasing risk and others offering protection.

A new non-invasive method can analyze skin mRNA to understand skin diseases better.

Genetic variants at 20p11 increase baldness risk in Chinese Han people.

The method accurately measures certain steroids in human hair, showing different levels in males and females.

Five molecular elements identified as potential future targets for hair loss therapy.

The assay effectively identifies compounds that affect immune cell activation.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Pharmacists play a crucial role in customizing treatments and ensuring medication safety.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

A new classification for trichothiodystrophy helps identify genetic causes and potential treatments.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.